Autologous Umbilical Cord Blood Mononuclear Cells Therapy

OTHER3 trials

Sponsors

Guangdong Women and Children Hospital

Conditions

Bronchopulmonary DysplasiaEffect of DrugsGrowth and DevelopmentNeonatal DeathNeonatal Necrotizing EnterocolitisNutritionPrematurePreterm Infants

Early Phase 1

Effect of Autologous Cord Blood Mononuclear Cells for Digestive System in Preterm Neonates

Guangdong Women and Children HospitalGrowth and Development, Neonatal Necrotizing Enterocolitis, Nutrition +1

Start: 2021-09-01End: 2022-12-31Target: 60Updated: 2022-04-25

Phase 1

Safety and Efficacy of Autologous Umbilical Cord Blood Mononuclear Cells Transfusion in Neonates

Guangdong Women and Children HospitalEffect of Drugs, Neonatal Death, Safety Issues

Start: 2017-02-10End: 2017-05-15Target: 200Updated: 2017-04-10

Phase 2

Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates

CompletedNCT02999373

Guangdong Women and Children HospitalBronchopulmonary Dysplasia, Neonatal Death, Premature

Start: 2018-07-01End: 2020-01-01Updated: 2021-11-02

Related Papers

Cord blood stem cell‑derived Angptl7 ameliorates the severity of bronchopulmonary dysplasia via anti‑inflammatory and proangiogenic effects

Molecular Medicine Reports2023-11-206 citations

Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomes.

2023-02-1617 citations

Use of Autologous Cord Blood Mononuclear Cells Infusion for the Prevention of Bronchopulmonary Dysplasia in Extremely Preterm Neonates: A Study Protocol for a Placebo-Controlled Randomized Multicenter Trial [NCT04440670]

Frontiers in Pediatrics2020-04-021 citations